日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Inflammatory exacerbation of hepatic alveolar echinococcosis during dupilumab therapy: A case report

度普利尤单抗治疗期间肝泡型棘球蚴病炎症加重:病例报告

Hasebe, Takumu; Tanaka, Honami; Abe, Masami; Hasebe, Chitomi; Otake, Shin; Hayashi, Hidemi; Ota, Yu; Sawada, Koji; Mizukami, Shoichiro; Takahashi, Hiroyuki; Kitada, Masahiro; Sako, Yasuhito; Sakata, Akira; Yuzawa, Sayaka; Yokoo, Hideki

Effect of treatment periods on efficacy of glecaprevir and pibrentasvir in chronic hepatitis C: A nationwide, prospective, multicenter study

治疗周期对格卡瑞韦和哌仑他韦治疗慢性丙型肝炎疗效的影响:一项全国性、前瞻性、多中心研究

Morita, Atsuhiro; Tamaki, Nobuharu; Kobashi, Haruhiko; Mori, Nami; Tsuji, Keiji; Takaki, Shintaro; Hasebe, Chitomi; Akahane, Takehiro; Ochi, Hironori; Mashiba, Toshie; Urawa, Naohito; Fujii, Hideki; Mitsuda, Akeri; Kondo, Masahiko; Ogawa, Chikara; Uchida, Yasushi; Narita, Ryoichi; Marusawa, Hiroyuki; Kubotsu, Yoshihito; Matsushita, Tomomichi; Shigeno, Masaya; Yoshida, Hideo; Tanaka, Katsuaki; Okamoto, Eisuke; Kasai, Toyotaka; Ishii, Toru; Okada, Kazuhiko; Kurosaki, Masayuki; Izumi, Namiki

Clinical Characteristics of Steatotic Liver Disease Categories in a Large Cohort of Japanese Health Checkup Participants

日本大型健康体检参与者队列中脂肪肝疾病各类别的临床特征

Kamada, Yoshihiro; Fujii, Hideki; Suzuki, Yuichiro; Sawada, Koji; Tatsuta, Miwa; Maeshiro, Tatsuji; Tobita, Hiroshi; Tsutsumi, Tsubasa; Akahane, Takemi; Hasebe, Chitomi; Kawanaka, Miwa; Kessoku, Takaomi; Eguchi, Yuichiro; Syokita, Hayashi; Nakajima, Atsushi; Kamada, Tomoari; Yoshiji, Hitoshi; Kawaguchi, Takumi; Sakugawa, Hiroshi; Morishita, Asahiro; Masaki, Tsutomu; Ohmura, Takumi; Watanabe, Toshio; Yoda, Yoshioki; Enomoto, Nobuyuki; Ono, Masafumi; Fuyama, Kanako; Okada, Kazufumi; Nishimoto, Naoki; Ito, Yoichi M; Takahashi, Hirokazu; Sumida, Yoshio

Necessity for surveillance for hepatocellualr carcinoma in older patients with chronic hepatitis C who achieved sustained virological response

对于已获得持续病毒学应答的慢性丙型肝炎老年患者,有必要进行肝细胞癌监测。

Ishido, Shun; Tamaki, Nobuharu; Kurosaki, Masayuki; Mori, Nami; Tsuji, Keiji; Hasebe, Chitomi; Mashiba, Toshie; Ochi, Hironori; Yasui, Yutaka; Akahane, Takehiro; Furuta, Koichiro; Kobashi, Haruhiko; Fujii, Hideki; Ishii, Toru; Marusawa, Hiroyuki; Kondo, Masahiko; Kusakabe, Atsunori; Yoshida, Hideo; Uchida, Yasushi; Tada, Toshifumi; Nakamura, Shinichiro; Mitsuda, Akari; Ogawa, Chikara; Arai, Hirotaka; Murohisa, Toshimitsu; Uebayashi, Minoru; Izumi, Namiki

Hepatocellular Carcinoma Risk Assessment for Patients With Advanced Fibrosis After Eradication of Hepatitis C Virus

丙型肝炎病毒根除后晚期纤维化患者的肝细胞癌风险评估

Tamaki, Nobuharu; Kurosaki, Masayuki; Yasui, Yutaka; Mori, Nami; Tsuji, Keiji; Hasebe, Chitomi; Joko, Kouji; Akahane, Takehiro; Furuta, Koichiro; Kobashi, Haruhiko; Kimura, Hiroyuki; Yagisawa, Hitoshi; Marusawa, Hiroyuki; Kondo, Masahiko; Kojima, Yuji; Yoshida, Hideo; Uchida, Yasushi; Tada, Toshifumi; Nakamura, Shinichiro; Yasuda, Satoshi; Toyoda, Hidenori; Loomba, Rohit; Izumi, Namiki

A validation study of after direct-acting antivirals recommendation for surveillance score for the development of hepatocellular carcinoma in patients with hepatitis C virus infection who had received direct-acting antiviral therapy and achieved sustained virological response

一项验证性研究旨在评估直接抗病毒药物治疗后,丙型肝炎病毒感染患者肝细胞癌发生监测评分推荐值在接受直接抗病毒药物治疗并达到持续病毒学应答后的应用价值。

Tada, Toshifumi; Kurosaki, Masayuki; Tamaki, Nobuharu; Yasui, Yutaka; Mori, Nami; Tsuji, Keiji; Hasebe, Chitomi; Joko, Koji; Akahane, Takehiro; Furuta, Koichiro; Kobashi, Haruhiko; Kimura, Hiroyuki; Yagisawa, Hitoshi; Marusawa, Hiroyuki; Kondo, Masahiko; Kojima, Yuji; Yoshida, Hideo; Uchida, Yasushi; Nakamura, Shinichiro; Izumi, Namiki

Real-world long-term analysis of daclatasvir plus asunaprevir in patients with hepatitis C virus infection

达克拉他韦联合阿舒那韦治疗丙型肝炎病毒感染患者的真实世界长期分析

Fujii, Hideki; Kimura, Hiroyuki; Hasebe, Chitomi; Akahane, Takehiro; Satou, Takashi; Kusakabe, Atsunori; Kojima, Yuji; Kondo, Masahiko; Marusawa, Hiroyuki; Kobashi, Haruhiko; Tsuji, Keiji; Ogawa, Chikara; Uchida, Yasushi; Joko, Kouji; Mitsuda, Akeri; Kurosaki, Masayuki; Izumi, Namiki

General evaluation score for predicting the development of hepatocellular carcinoma in patients with advanced liver fibrosis associated with hepatitis C virus genotype 1 or 2 after direct-acting antiviral therapy

预测丙型肝炎病毒基因1型或2型相关晚期肝纤维化患者在接受直接抗病毒治疗后发生肝细胞癌的总体评估评分

Tada, Toshifumi; Kurosaki, Masayuki; Tamaki, Nobuharu; Yasui, Yutaka; Mori, Nami; Tsuji, Keiji; Hasebe, Chitomi; Joko, Koji; Akahane, Takehiro; Furuta, Koichiro; Kobashi, Haruhiko; Fujii, Hideki; Ishii, Toru; Marusawa, Hiroyuki; Kondo, Masahiko; Kojima, Yuji; Yoshida, Hideo; Uchida, Yasushi; Nakamura, Shinichiro; Izumi, Namiki

Change in Fibrosis 4 Index as Predictor of High Risk of Incident Hepatocellular Carcinoma After Eradication of Hepatitis C Virus

肝纤维化4指数的变化可作为丙型肝炎病毒根除后发生肝细胞癌高风险的预测指标

Tamaki, Nobuharu; Kurosaki, Masayuki; Yasui, Yutaka; Mori, Nami; Tsuji, Keiji; Hasebe, Chitomi; Joko, Koji; Akahane, Takehiro; Furuta, Koichiro; Kobashi, Haruhiko; Kimura, Hiroyuki; Yagisawa, Hitoshi; Marusawa, Hiroyuki; Kondo, Masahiko; Kojima, Yuji; Yoshida, Hideo; Uchida, Yasushi; Loomba, Rohit; Izumi, Namiki

The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study

来自一项全国多中心研究的日本不可切除肝细胞癌患者接受乐伐替尼治疗的真实世界数据

Tsuchiya, Kaoru; Kurosaki, Masayuki; Sakamoto, Azusa; Marusawa, Hiroyuki; Kojima, Yuji; Hasebe, Chitomi; Arai, Hirotaka; Joko, Kouji; Kondo, Masahiko; Tsuji, Keiji; Sohda, Tetsuro; Kimura, Hiroyuki; Ogawa, Chikara; Uchida, Yasushi; Wada, Shuichi; Kobashi, Haruhiko; Furuta, Koichiro; Shigeno, Masaya; Kusakabe, Atsunori; Akahane, Takehiro; Narita, Ryoichi; Yoshida, Hideo; Mitsuda, Akeri; Ide, Yasushi; Matsushita, Tomomichi; Izumi, Namiki; On Behalf Of Japanese Red Cross Liver Study Group